March 22, 2024

Resumo 5342: Avaliação de terapias baseadas em células T autólogas e alogênicas em modelos de tumor xenotransplantados ex-vivo e in-vivo

Key Points

Key points are not available for this paper at this time.

Abstract

Resumo O campo da imunoterapia adotiva baseada em células T, incluindo linfócitos infiltrantes de tumor (TILs), receptor de células T (TCR) Parte 1 (Resumos Regulares); 5-10 abr 2024; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Resumo nº 5342.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Sherry Liu

Jasmine Borroel

Carmen Sunico

Journals

Cancer Research

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Resumo 5342: Avaliação de terapias baseadas em células T autólogas e alogênicas em modelos de tumor xenotransplantados ex-vivo e in-vivo

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider